downregulation of bax/bcl-2 expression during apoptosis in thehippocampus of diabetic male wistar rats: ameliorative effects of peganum harmala seed extract

Background: apoptosis is proposed as a possible mechanism for diabetes-induced hippocampal neuronal cell death. numerous studies have suggested that the therapeutic properties of plants, such as antioxidant and anti-apoptotic, are effective in improving the complications of diabetes in the hippocampus. objectives: this study aimed to evaluate the anti-apoptotic properties of peganum harmala (p. harmala) in the brain hippocampal cells of diabetic rats. methods: in this experimental study, 48 male wistar rats were divided into six groups (n = 8) as follows: control (c), diabetic (d), harmine (h), diabetic plus harmine (dh), seed extract (s), and diabetic plus seed extract (ds). a single dose of streptozotocin (stz) (60 mg/kg) was enough to cause diabetes. seed extract and harmine were given at 150 mg/kg and 6.5 mg/kg, respectively (daily by oral gavage for 28 days). the glucose levels in the blood were measured, and the histological staining of the hippocampus was examined. percentages of apoptotic hippocampal cells were identified with flow cytometry. bax and bcl-2 expression was assayed via real time- polymerase chain reaction (pcr) and western blot. results: in dh (p = 0.001) and ds (p = 0.01) rats, the mean fasting blood glucose level significantly reduced compared with the d group. bax and bcl-2 expression at both mrna and protein levels significantly differed between the d group and other groups (p = 0.01). harmine and the seed extract considerably reduced the bax/bcl-2 ratio in the hippocampal cells compared to the d group (p = 0.001). conclusions: streptozotocin-induced apoptosis in the hippocampus of diabetic rats was reduced by administering the seed extract of peganum harmala. the p. harmala seed extract and its active ingredient, harmine, could be used as anti-apoptotic drugs.